<?xml version="1.0" encoding="UTF-8"?>
<ref id="B172-biomedicines-08-00060">
 <label>172.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Schulze</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kemmer</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Weitz</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Wernecke</surname>
    <given-names>K.D.</given-names>
   </name>
   <name>
    <surname>Schirrmacher</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Schlag</surname>
    <given-names>P.M.</given-names>
   </name>
  </person-group>
  <article-title>Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastasis: Results of a prospective randomized trial</article-title>
  <source>Cancer Immunol. Immunother.</source>
  <year>2009</year>
  <volume>58</volume>
  <fpage>61</fpage>
  <lpage>69</lpage>
  <pub-id pub-id-type="doi">10.1007/s00262-008-0526-1</pub-id>
  <pub-id pub-id-type="pmid">18488223</pub-id>
 </element-citation>
</ref>
